Work

Exploring the Influence of the Dopamine D3 and Cannabinoid CB1 Receptors in Substance Use Disorders: A look into human drug reinforcement and cue-reactivity

Year: 2021
Type: dissertation
Abstract: Introduction: There is a growing need for the better understanding of the neurobiology that underlies substance use disorder. The dopamine D3 receptor (DRD3) has received research attention recently due to its apparent involvement in alcohol use disorder (AUD) and tobacco use disorder (TUD). The current series of human laboratory experimentations aim to explore the role of DRD3 in both AUD and TUD using a variety of investigative techniques. The final study serves as a contrast that explores the cannabinoid CB1 (CB1R) receptor in TUD. Methods: Study 1 examines DRD3 levels between AUD subjects and healthy controls using positron emission tomography and a DRD3 preferring radiotracer, [11C]-(+)-PHNO. The relationship between [11C]-(+)-PHNO binding and AUD phenotypes, motivation to consume alcohol (measured by an intravenous self-administration procedure) and alcohol cue elicited craving (measured by cue-reactivity), is also explored in AUD subjects. Study 2 and 3 respectively investigate DRD3 and CB1R single nucleotide polymorphisms (SNPs) in phenotypes of TUD (both nicotine reinforcement [measured by forced choice] as well as craving [measured by cue-reactivity]). Results: In study 1, there was a global reduction of [11C]-(+)-PHNO binding, reflecting DRD2/3 levels, in AUD subjects compared to healthy. [11C]-(+)-PHNO binding in the limbic striatum was positively associated with alcohol cue-elicited craving, however this and no other association withstood Bonferroni corrections. In study 2, the Glycine allele carriers of the DRD3 Ser9Gly SNP experienced a blunted smoking cue-elicited craving, but the SNP showed no effect on nicotine reinforcement. On the other hand, in study 3, the C allele carriers of the rs2023239 CB1R SNP demonstrated lower relative nicotine reinforcement but this SNP did not affect cue-reactivity. Conclusion: Despite discrepant methods, these results seem to point to a potentially larger role of DRD3 in drug cue-associated craving compared to drug reinforcement as measured by these laboratory procedures. That said, understanding the neurobiological mechanisms underlying this relationship requires more research as the 2 studies point to different directions regarding the DRD3 and craving relationship. Therefore, further validation of the clinical utility of DRD3 as a potential drug target for substance use disorder pharmacotherapy is needed.
Language: English
Open Access status: green
OpenAlex ID: W7066086599
Cites: 356
Cited by:
Related to: 10